よむ、つかう、まなぶ。
07 参考資料２－１ 帯状疱疹ワクチン ファクトシート (48 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_36248.html |
| 出典情報 | 厚生科学審議会 予防接種・ワクチン分科会 予防接種基本方針部会 ワクチン評価に関する小委員会（第21回 11／9）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
71. Harding SP, Porter SM. Oral acyclovir in herpes zoster ophthalmicus. Current eye research
1991;10 Suppl:177-82.
72. Beutner KR, Friedman DJ, Forszpaniak C, Andersen PL, Wood MJ. Valaciclovir compared
with acyclovir for improved therapy for herpes zoster in immunocompetent adults.
Antimicrob Agents Chemother 1995; 39: 1546-53.
73. Degreef H. Famciclovir, a new oral antiherpes drug: results of the first controlled clinical
study demonstrating its efficacy and safety in the treatment of uncomplicated herpes zoster
in immunocompetent patients. Int J Antimicrob Agents 1994; 4(4): 241-6.
74. Dworkin RH, Boon RJ, Griffin DR, Phung D. Postherpetic neuralgia: impact of famciclovir,
age, rash severity, and acute pain in herpes zoster patients. J Infect Dis 1998; 178 Suppl 1:
S76-80.
75. Tyring S, Barbarash RA, Nahlik JE, Cunningham A, Marley J, Heng M, Jones T, Rea T,
Boon R, Saltzman R. Famciclovir for the treatment of acute herpes zoster: effects on
acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled
trial. Collaborative Famciclovir Herpes Zoster Study Group. Ann Intern Med 1995; 123:
89-96.
76. Wassilew SW, Wutzler P. Oral brivudin in comparison with acyclovir for herpes zoster: a
survey study on postherpetic neuralgia. Antiviral Res 2003; 59 :57-60.
77. Baena-Cañada JM, Martínez MJ, García-Olmedo O, Jiménez-Bárcenas R, Muriel-Cueto P.
Interaction between capecitabine and brivudin in a patient with breast cancer. Nat Rev Clin
Oncol 2010; 7: 55-8.
78. Rätz Bravo AE, Hofer S, Krähenbühl S, Ludwig C. Fatal drug-drug interaction of brivudine
and capecitabine. Acta Oncol 2009; 48: 631-3.
79. Whitley RJ, Weiss H, Gnann JW Jr, Tyring S, Mertz GJ, Pappas PG, Schleupner CJ,
Hayden F, Wolf J, Soong SJ. Acyclovir with and without prednisone for the treatment of
herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and
Infectious Diseases Collaborative Antiviral Study Group. Ann Intern Med 1996; 125:
376-83.
80. Wood MJ, Johnson RW, McKendrick MW, Taylor J, Mandal BK, Crooks J. A randomized
trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute
herpes zoster. N Engl J Med 1994; 330: 896-900.
81. McQuay HJ, Tramer M, Nye BA, Carroll D, Wiffen PJ, Moore RA. A systematic review of
antidepressants in neuropathic pain. Pain 1996; 68(2-3): 217-27.
82. Kumar V, Krone K, Mathieu A. Neuraxial and sympathetic blocks in herpes zoster and
postherpetic neuralgia: an appraisal of current evidence. Reg Anesth Pain Med 2004;
29(5):454-61
43
1991;10 Suppl:177-82.
72. Beutner KR, Friedman DJ, Forszpaniak C, Andersen PL, Wood MJ. Valaciclovir compared
with acyclovir for improved therapy for herpes zoster in immunocompetent adults.
Antimicrob Agents Chemother 1995; 39: 1546-53.
73. Degreef H. Famciclovir, a new oral antiherpes drug: results of the first controlled clinical
study demonstrating its efficacy and safety in the treatment of uncomplicated herpes zoster
in immunocompetent patients. Int J Antimicrob Agents 1994; 4(4): 241-6.
74. Dworkin RH, Boon RJ, Griffin DR, Phung D. Postherpetic neuralgia: impact of famciclovir,
age, rash severity, and acute pain in herpes zoster patients. J Infect Dis 1998; 178 Suppl 1:
S76-80.
75. Tyring S, Barbarash RA, Nahlik JE, Cunningham A, Marley J, Heng M, Jones T, Rea T,
Boon R, Saltzman R. Famciclovir for the treatment of acute herpes zoster: effects on
acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled
trial. Collaborative Famciclovir Herpes Zoster Study Group. Ann Intern Med 1995; 123:
89-96.
76. Wassilew SW, Wutzler P. Oral brivudin in comparison with acyclovir for herpes zoster: a
survey study on postherpetic neuralgia. Antiviral Res 2003; 59 :57-60.
77. Baena-Cañada JM, Martínez MJ, García-Olmedo O, Jiménez-Bárcenas R, Muriel-Cueto P.
Interaction between capecitabine and brivudin in a patient with breast cancer. Nat Rev Clin
Oncol 2010; 7: 55-8.
78. Rätz Bravo AE, Hofer S, Krähenbühl S, Ludwig C. Fatal drug-drug interaction of brivudine
and capecitabine. Acta Oncol 2009; 48: 631-3.
79. Whitley RJ, Weiss H, Gnann JW Jr, Tyring S, Mertz GJ, Pappas PG, Schleupner CJ,
Hayden F, Wolf J, Soong SJ. Acyclovir with and without prednisone for the treatment of
herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and
Infectious Diseases Collaborative Antiviral Study Group. Ann Intern Med 1996; 125:
376-83.
80. Wood MJ, Johnson RW, McKendrick MW, Taylor J, Mandal BK, Crooks J. A randomized
trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute
herpes zoster. N Engl J Med 1994; 330: 896-900.
81. McQuay HJ, Tramer M, Nye BA, Carroll D, Wiffen PJ, Moore RA. A systematic review of
antidepressants in neuropathic pain. Pain 1996; 68(2-3): 217-27.
82. Kumar V, Krone K, Mathieu A. Neuraxial and sympathetic blocks in herpes zoster and
postherpetic neuralgia: an appraisal of current evidence. Reg Anesth Pain Med 2004;
29(5):454-61
43